Dexrazoxane Hydrochloride Injection Shortage
Last Updated: February 13, 2024
Status: Current
Products Affected - Description
-
- Dexrazoxane injection, Eugia US, 250 mg, vial, 1 count, NDC 55150-0434-01
- Dexrazoxane injection, Eugia US, 500 mg, vial, 1 count, NDC 55150-0437-01
- Dexrazoxane injection, Fosun Pharma, 250 mg, vial, 1 count, NDC 72266-0235-01
- Dexrazoxane injection, Fosun Pharma, 500 mg, vial, 1 count, NDC 72266-0101-01
Reason for the Shortage
-
- Eugia did not provide a reason for the shortage.
- Breckenridge discontinued dexrazoxane injection in September 2023.
- Fosun did not provide a reason for the shortage.
- Hikma has dexrazoxane injection available.
- Information regarding Almaject product availability is forthcoming.
Available Products
-
- Dexrazoxane injection, Hikma, 250 mg, vial, 1 count, NDC 00143-9247-01
- Dexrazoxane injection, Hikma, 500 mg, vial, 1 count, NDC 00143-9248-01
Estimated Resupply Dates
-
- Eugia has dexrazoxane 250 mg and 500 mg vials on intermittent back order and the company is releasing supplies as they become available.
- Fosun has dexrazoxane 250 mg and 500 mg vials on back order and the company cannot estimate a release date.
Updated
Created February 13, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.